Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for ORIC Pharmaceuticals

    Client Virtual Booth

    ORIC PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    ORIC Pharmaceuticals
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    240 E. Grand Ave, 2nd Floor South San Francisco, CA 94080
    Telephone
    Telephone
    (650) 388-5600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://oricpharma.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    ORIC Doses First NSCLC Patients In ORIC-114 Phase 1b Expansion
    ORIC Doses First NSCLC Patients In ORIC-114 Phase 1b Expansion

    https://www.globenewswire.com/news-release/2024/04/15/2863166/0/en/ORIC-Pharmaceuticals-Announces-First-Patients-Dosed-Across-Three-Expansion-Cohorts-in-Phase-1b-Trial-of-ORIC-114-in-Patients-with-Mutated-NSCLC.html

    GLOBENEWSWIRE
    15 Apr 2024
    Share Share
    ORIC Pharmaceuticals Presents Data on Two Programs at the 2024 AACR
    ORIC Pharmaceuticals Presents Data on Two Programs at the 2024 AACR

    https://www.globenewswire.com/news-release/2024/04/08/2859138/0/en/ORIC-Pharmaceuticals-Presents-Preclinical-Data-on-Two-Programs-at-the-2024-American-Association-for-Cancer-Research-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    08 Apr 2024
    Share Share
    ORIC Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    ORIC Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/04/05/2858745/0/en/ORIC-Pharmaceuticals-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Apr 2024
    Share Share
    ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
    ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

    https://www.globenewswire.com/news-release/2024/04/04/2858218/0/en/ORIC-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Apr 2024
    Share Share
    ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
    ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/03/11/2844147/0/en/ORIC-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Operational-Updates.html

    GLOBENEWSWIRE
    11 Mar 2024
    Share Share
    ORIC Pharma to Present at the Leerink Partners Global Biopharma Conference
    ORIC Pharma to Present at the Leerink Partners Global Biopharma Conference

    https://www.globenewswire.com//news-release/2024/03/06/2841802/0/en/ORIC-Pharmaceuticals-to-Present-at-the-Leerink-Partners-Global-Biopharma-Conference.html

    GLOBENEWSWIRE
    06 Mar 2024
    Share Share
    ORIC Pharmaceuticals Announces Multiple Presentations
    ORIC Pharmaceuticals Announces Multiple Presentations

    https://www.globenewswire.com//news-release/2024/03/05/2840945/0/en/ORIC-Pharmaceuticals-Announces-Multiple-Presentations-at-the-2024-American-Association-for-Cancer-Research-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    05 Mar 2024
    Share Share
    ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/03/01/2839078/0/en/ORIC-Pharmaceuticals-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Mar 2024
    Share Share
    ORIC Pharma to Participate in the Citi 2024 Virtual Oncology Leadership Summit
    ORIC Pharma to Participate in the Citi 2024 Virtual Oncology Leadership Summit

    https://www.globenewswire.com//news-release/2024/02/14/2829482/0/en/ORIC-Pharmaceuticals-to-Participate-in-the-Citi-2024-Virtual-Oncology-Leadership-Summit.html

    GLOBENEWSWIRE
    14 Feb 2024
    Share Share
    ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com//news-release/2024/02/02/2823063/0/en/ORIC-Pharmaceuticals-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Feb 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search